4//SEC Filing
Cowan Chad 4
Accession 0001062993-25-005293
CIK 0001850119other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:31 PM ET
Size
8.4 KB
Accession
0001062993-25-005293
Insider Transaction Report
Form 4
Cowan Chad
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-03-11+19,500→ 230,306 total - Award
Stock Option (right to buy)
2025-03-11+19,500→ 19,500 totalExercise: $0.60Exp: 2035-03-11→ Common Stock (19,500 underlying)
Holdings
- 10,697(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
- [F3]The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0002039294
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 7:31 PM ET
- Size
- 8.4 KB